Slides from a presentation Adrian gave at the 2018 ISPOR Europe conference in Barcelona on the topic of patient-centred care and what it means for medicine in the welfare states of Europe.
Health Care "Prime" - The Future of the Ownership, Organization, Payment, and...Polsinelli PC
The potential for disruption and disaggregation of traditional and incumbent players is occurring across the health care ecosystem and care continuum, and may accelerate through the intended and unintended consequences of this innovative new venture. Is this partnership a seminal event in defining the future of health care? Author William Gibson said, “The future is already here – it’s just not very evenly distributed.” This statement applies as the future of health care fast approaches, but with variability across stakeholders, their businesses, and the communities in which they provide care as part of one of America’s largest industries.
A diverse panelist group will bring a broad range of current perspectives and insights related to this partnership. From the base of the panelists’ unique perspectives, they will discuss their views on the likely near-, mid- and long-term implications of this announced venture on the ownership, organization, payment, and delivery of health care products, supplies and services in America.
Many factors affect a healthcare organization’s ability to provide quality patient care. But the most powerful key to better patient outcomes isn’t vanguard medical technology, an organization’s number of specialty providers, or even add-on programs designed to promote preventative care. Instead, recent research and practical in-the-field experience demonstrates that healthcare
organizations can create the most profound improvements in patient care and satisfaction levels simply by improving employee engagement.
Martin Gaynor: "Inside the ‘Black Box’ of Health Care Spending Data?" 2.18.16reportingonhealth
Martin Gaynor's slides from the Center for Health Journalism webinar "Inside the ‘Black Box’ of Health Care Spending Data," 2.18.16
http://www.centerforhealthjournalism.org/content/inside-black-box-health-care-spending-data
Health Care "Prime" - The Future of the Ownership, Organization, Payment, and...Polsinelli PC
The potential for disruption and disaggregation of traditional and incumbent players is occurring across the health care ecosystem and care continuum, and may accelerate through the intended and unintended consequences of this innovative new venture. Is this partnership a seminal event in defining the future of health care? Author William Gibson said, “The future is already here – it’s just not very evenly distributed.” This statement applies as the future of health care fast approaches, but with variability across stakeholders, their businesses, and the communities in which they provide care as part of one of America’s largest industries.
A diverse panelist group will bring a broad range of current perspectives and insights related to this partnership. From the base of the panelists’ unique perspectives, they will discuss their views on the likely near-, mid- and long-term implications of this announced venture on the ownership, organization, payment, and delivery of health care products, supplies and services in America.
Many factors affect a healthcare organization’s ability to provide quality patient care. But the most powerful key to better patient outcomes isn’t vanguard medical technology, an organization’s number of specialty providers, or even add-on programs designed to promote preventative care. Instead, recent research and practical in-the-field experience demonstrates that healthcare
organizations can create the most profound improvements in patient care and satisfaction levels simply by improving employee engagement.
Martin Gaynor: "Inside the ‘Black Box’ of Health Care Spending Data?" 2.18.16reportingonhealth
Martin Gaynor's slides from the Center for Health Journalism webinar "Inside the ‘Black Box’ of Health Care Spending Data," 2.18.16
http://www.centerforhealthjournalism.org/content/inside-black-box-health-care-spending-data
Pittsburgh Nonprofit Summit - Health Care & Health Care Reform - Implications...GPNP
The health care act is difficult to navigate and nonprofits were written into the act under the auspices of small businesses, making it even more confusing to understand. Gain insights from experts about the intent of the act and the act in its current draft, how it will impact nonprofits as small businesses, the impact on staff, those we serve, and on society at large. Additionally, portions of the act are still being debated and amended; learn of the potential changes and points where the nonprofit sector can influence the outcome.
St. Luke's Health System President and CEO Dr. David Pate's presentation to at the state of Idaho's Medicaid Managed Care Public Forum held in Boise on Dec. 13, 2011.
Pandemic Influenza: Hospital and Clinic Planning by Dan O'LaughlinMark Engebretson
Dan O'Laughlin's presentation at the Sept. 10, 2009 H1N1: Lessons from the Southern Hemisphere and Minnesota's Preparedness at the University of Minnesota.
Leanne Wells, Chief Executive Officer, Consumers Health Forum of Australia, gave the Ian Webster Health for All Oration to the annual forum of the Centre for Primary Health Care and Equity on 13 August 2015.
Sabriya Rice: "Does ‘Pay for Performance’ Work?" 6.28.16reportingonhealth
Sabriya Rice's slides from the Center for Health Journalism webinar "Does ‘Pay for Performance’ Work?" 6.28.16
http://www.centerforhealthjournalism.org/content/does-pay-performance-work
The Arizona Crisis Now Model: AHCCCS OutcomesDavid Covington
In 2016, the National Action Alliance for Suicide Prevention published “Crisis Now: Transforming Care is Within Our Reach.” Alignment with these practices cuts cost of care substantially, reduces the need for psychiatric hospital bed usage, ED visits and law enforcement overuse; resulting in better health and declines in suicide rate, justice system involvement/ incarcerations and psychiatric boarding. These challenges are simply greater than previously acknowledged, but the Washington State supreme court ruling on the unconstitutionality of boarding, the suicide death of Virginia State Senator Creigh Deeds’ son, the insistence of hospitals nationwide about the costs and safety and the series of violent incidents from Columbine forward are changing the expectations. These innovative approaches pioneered under the leadership of Arizona Medicaid are now being replicated throughout the US.
The health protection system is the object of constant
pressures and difficulties in mitigating them, and even
more so eliminating or at least reducing them. Changes
are undertaken under the influence of a one-sided
political assessment, the interests of various groups of
participants or the protests of successive groups of medical
staff. There is no professional and fully documented
diagnosis of the system, made by independent experts,
which could serve as the basis for a comprehensive
health protection reform plan, rather than individual,
incidental changes that disrupt the system’s already
very fragile balance. A well thought-out reform, properly
distributed over time, so that at no point does it cause
negative health effects. A reform agreed among stake-
holders and adopted with understanding of the need
for changes, so that it is supported by society. A reform
for which there will be funds, institutions and engaged
professionals – leaders in health protection. A reform
that won’t be criticized or changed when the government
changes. Such a reform is waiting to be presented and
debated. We begin this process by pointing out and
presenting the system’s main problems.
11 minutes agoJessica Dunne RE Discussion - Week 3COLLAPS.docxdrennanmicah
11 minutes ago
Jessica Dunne
RE: Discussion - Week 3
COLLAPSE
Top of Form
NURS 6050C: Policy and Advocacy for Improving Population Health
INITIAL POST
Economic Challenges of Healthcare Policy
The economics of the healthcare system in the United States is complex and fragmented. Costs associated with care and the prices healthcare consumers pay are determined by a wide variety of factors making it extremely difficult to find a one size fits all solution. Knickman and Kovner (2015) argue that healthcare is neither a commodity or a service, because of the high variabilities in need, cost, and consumption. The United States spends 80% of all healthcare revenue on just 20% of the population. Health insurance can be provided by the government, the private sector, or an employer. Some citizens do not have any form of healthcare coverage. Regardless of type, insurance coverage generally only pays a portion of the total healthcare cost leaving the consumer to pay the remaining balance. Moreover, reimbursement standards differ for facilities and providers. The government reimburses healthcare facilities, such as hospitals a fixed amount per patient, which creates a higher incentive to work efficiently. Healthcare providers, on the other hand, are reimbursed based on a fee for service model, meaning the more services they provide, the more money they are reimbursed (Knickman & Kovner, 2015).
Reindart (2010) maintains the passage of the Affordable Care Act (ACA) created more strain on the system by adding approximately 30 million uninsured Americans to the market. The projected cost to provide such coverage is around 8 billion to 1 trillion dollars over the next decade. However, the estimated expense of healthcare with no legislative intervention is 35 trillion dollars over the next decade (Reindart, 2010). Laureate Education (2012) contends that the human resources required to provide healthcare to an additional 30 million people is another consideration the ACA does not address. The United States is already experiencing staff shortages for key healthcare jobs like nurses and physicians. Additionally, with baby boomers retiring from the workforce and simultaneously needing more healthcare resources as they age will inevitably exacerbate the shortage of providers (Laureate Education, 2012).
Ethical Considerations
It is important to recognize that the private sector often follows the public sector when deciding what services will be covered (Knickman & Kovner, 2015). Therefore, the implications of Medicare deciding not to pay for a drug or service will likely affect the entire population. Stein (2010) asserts that cost should not be a consideration in determining if medications or services will be paid for by Medicare. Nonetheless, that is what happened with Provenge, a vaccine indicated for late stage prostate cancer patients. The drug prolonged the lifespan of patients by about four months. Provenge costs around 93,000 dollars per p.
Pittsburgh Nonprofit Summit - Health Care & Health Care Reform - Implications...GPNP
The health care act is difficult to navigate and nonprofits were written into the act under the auspices of small businesses, making it even more confusing to understand. Gain insights from experts about the intent of the act and the act in its current draft, how it will impact nonprofits as small businesses, the impact on staff, those we serve, and on society at large. Additionally, portions of the act are still being debated and amended; learn of the potential changes and points where the nonprofit sector can influence the outcome.
St. Luke's Health System President and CEO Dr. David Pate's presentation to at the state of Idaho's Medicaid Managed Care Public Forum held in Boise on Dec. 13, 2011.
Pandemic Influenza: Hospital and Clinic Planning by Dan O'LaughlinMark Engebretson
Dan O'Laughlin's presentation at the Sept. 10, 2009 H1N1: Lessons from the Southern Hemisphere and Minnesota's Preparedness at the University of Minnesota.
Leanne Wells, Chief Executive Officer, Consumers Health Forum of Australia, gave the Ian Webster Health for All Oration to the annual forum of the Centre for Primary Health Care and Equity on 13 August 2015.
Sabriya Rice: "Does ‘Pay for Performance’ Work?" 6.28.16reportingonhealth
Sabriya Rice's slides from the Center for Health Journalism webinar "Does ‘Pay for Performance’ Work?" 6.28.16
http://www.centerforhealthjournalism.org/content/does-pay-performance-work
The Arizona Crisis Now Model: AHCCCS OutcomesDavid Covington
In 2016, the National Action Alliance for Suicide Prevention published “Crisis Now: Transforming Care is Within Our Reach.” Alignment with these practices cuts cost of care substantially, reduces the need for psychiatric hospital bed usage, ED visits and law enforcement overuse; resulting in better health and declines in suicide rate, justice system involvement/ incarcerations and psychiatric boarding. These challenges are simply greater than previously acknowledged, but the Washington State supreme court ruling on the unconstitutionality of boarding, the suicide death of Virginia State Senator Creigh Deeds’ son, the insistence of hospitals nationwide about the costs and safety and the series of violent incidents from Columbine forward are changing the expectations. These innovative approaches pioneered under the leadership of Arizona Medicaid are now being replicated throughout the US.
The health protection system is the object of constant
pressures and difficulties in mitigating them, and even
more so eliminating or at least reducing them. Changes
are undertaken under the influence of a one-sided
political assessment, the interests of various groups of
participants or the protests of successive groups of medical
staff. There is no professional and fully documented
diagnosis of the system, made by independent experts,
which could serve as the basis for a comprehensive
health protection reform plan, rather than individual,
incidental changes that disrupt the system’s already
very fragile balance. A well thought-out reform, properly
distributed over time, so that at no point does it cause
negative health effects. A reform agreed among stake-
holders and adopted with understanding of the need
for changes, so that it is supported by society. A reform
for which there will be funds, institutions and engaged
professionals – leaders in health protection. A reform
that won’t be criticized or changed when the government
changes. Such a reform is waiting to be presented and
debated. We begin this process by pointing out and
presenting the system’s main problems.
11 minutes agoJessica Dunne RE Discussion - Week 3COLLAPS.docxdrennanmicah
11 minutes ago
Jessica Dunne
RE: Discussion - Week 3
COLLAPSE
Top of Form
NURS 6050C: Policy and Advocacy for Improving Population Health
INITIAL POST
Economic Challenges of Healthcare Policy
The economics of the healthcare system in the United States is complex and fragmented. Costs associated with care and the prices healthcare consumers pay are determined by a wide variety of factors making it extremely difficult to find a one size fits all solution. Knickman and Kovner (2015) argue that healthcare is neither a commodity or a service, because of the high variabilities in need, cost, and consumption. The United States spends 80% of all healthcare revenue on just 20% of the population. Health insurance can be provided by the government, the private sector, or an employer. Some citizens do not have any form of healthcare coverage. Regardless of type, insurance coverage generally only pays a portion of the total healthcare cost leaving the consumer to pay the remaining balance. Moreover, reimbursement standards differ for facilities and providers. The government reimburses healthcare facilities, such as hospitals a fixed amount per patient, which creates a higher incentive to work efficiently. Healthcare providers, on the other hand, are reimbursed based on a fee for service model, meaning the more services they provide, the more money they are reimbursed (Knickman & Kovner, 2015).
Reindart (2010) maintains the passage of the Affordable Care Act (ACA) created more strain on the system by adding approximately 30 million uninsured Americans to the market. The projected cost to provide such coverage is around 8 billion to 1 trillion dollars over the next decade. However, the estimated expense of healthcare with no legislative intervention is 35 trillion dollars over the next decade (Reindart, 2010). Laureate Education (2012) contends that the human resources required to provide healthcare to an additional 30 million people is another consideration the ACA does not address. The United States is already experiencing staff shortages for key healthcare jobs like nurses and physicians. Additionally, with baby boomers retiring from the workforce and simultaneously needing more healthcare resources as they age will inevitably exacerbate the shortage of providers (Laureate Education, 2012).
Ethical Considerations
It is important to recognize that the private sector often follows the public sector when deciding what services will be covered (Knickman & Kovner, 2015). Therefore, the implications of Medicare deciding not to pay for a drug or service will likely affect the entire population. Stein (2010) asserts that cost should not be a consideration in determining if medications or services will be paid for by Medicare. Nonetheless, that is what happened with Provenge, a vaccine indicated for late stage prostate cancer patients. The drug prolonged the lifespan of patients by about four months. Provenge costs around 93,000 dollars per p.
Ethical Issues Of The Healthcare Essay
Essay on Careers in Healthcare
Changes In Healthcare Essay
Health Care Persuasive Essay
Essay on Quality Health Care
Essay On American Healthcare
Health Insurance Essay
Why Is Healthcare Important? Healthcare?
The Health Of A Health Care System
Ethical Issues in Healthcare Research Essay
Social Media And Health Care Essay
Why I Chose Healthcare
Healthcare in the United States Essay
Healthcare And The Healthcare Organization Essay
Healthcare Teams Essay
Current Health Care Issues Essay examples
Health Care Trends Essay examples
Essay On Healthcare In The United States
The Problem Of Health Care Essay
Inequality in Healthcare Essay examples
Cómo impactan las tendencias globales vinculadas a la salud, en la demanda y prestación de servicios en el mundo y en países de desarrollo medio como el Perú.
Conferencista:
- Ivy Teh, Managing Director de Clearstate
Cómo el fortalecimiento de los sistemas de salud impacta positivamente en la economía y cuáles son los roles y espacios de colaboración público- privados.
Expositores:
- Ivy Teh, Managing Director de Clearstate
Why Emplyers care about Pimary care 2008Paul Grundy
Employers are beginning to recognize that investing in the primary care foundation of the health care system may help address their problems of rising healthcare costs and uneven quality. Primary care faces a crisis as a growing number of U.S. medical graduates are avoiding primary care careers because of relatively low reimbursement and an unsatisfying work life. Yet a strong primary care sector has been associated with reduced health care costs and improved quality. Through the and other efforts, some large employers are engaged in initiatives tostrengthen primary care. [Health Affairs 27, no. 1 (2008): 151–158;
Using information to deliver world-class care at lower cost. CernerFundació TicSalut
III Edició "The British Experience in Technologies for Health". Hospital de Sant Pau, Barcelona. 9 de novembre de 2011. Esdeveniment organitzat per la Fundació TICSalut i el Departament de Comerç i Inversions del Consolat General Britànic a Barcelona, UK Trade & Investment, per posar en contacte oportunitats i coneixements entre el Regne Unit i Catalunya.
Essay on Definitions of Health
Healthcare in the United States Essay
Why Is Healthcare Important? Healthcare?
Essay On Healthcare System
Essay On Impact On Health Care
Essay On Home Health Care
Essay On Affordable Health Care
Health Care Persuasive Essay
Essay on Careers in Healthcare
Essay On Health Care
Persuasive Essay On Health Care
Essay On Healthcare In The United States
Inequality in Healthcare Essay examples
Health Care Trends Essay examples
Social Media And Health Care Essay
Essay on Quality Health Care
Essay on Health Care
The Health Of A Health Care System
Essay On Health Care
Persuasive Essay On Health Care
Essay On Health Care Reform
Essay on Quality Health Care
Essay On Healthcare System
Essay on Health Care
Essay on Careers in Healthcare
Essay On Health Care
Essay On Health Care
Health Insurance Essay
Essay about Health Care
Health Care Trends Essay examples
Essay On Health Care
Safe Patient Care
Nursing Education and Quality Patient Care Essay
Patient Safety Essay
Essay on Providing Quality Patient Care
Patient-Centered Care: A Case Study
Nursing Care Study Essays
Quality Patient Care Essay
Patient Centered Care Essay
Essay On Patient Centred Care
The Importance Of Patient Care And Quality Care
Patient Centred Care Essay
Patient-Centred Care Essay
Quality Patient Care Essay
Nurses Provide Excellent Patient Care Essay
Essay Patient Care Plan
My Experience With A Patient Essay
On 31 October 2019, Adrian Towse and Chris Henshall from the Office of Health Economics (OHE) presented at the G20 meeting on antimicrobial drugs R&D in Paris organised by the Wellcome Trust. The topic of their presentation was HTA and payment mechanisms for new drugs to tackle antimicrobial resistance.
This presentation looks at ways in which governments can set prices, including “cost plus”, value, and the external referencing of prices elsewhere. It looks at the role that competition can play in keeping down prices. In that context it briefly discusses pricing proposals being considered in Malaysia. It makes the case for using HTA to inform pricing decisions.
Adrian Towse
% GDP spending in UK, G5 countries and OECD upper middle income countries. W...Office of Health Economics
This presentation looks at rates of GDP spend on health care, distinguishing between categories of country (i.e. levels of GDP pre capita). It looks at the relationship between rates of spending and moves to universal health coverage, and explores alternative ways of increasing expenditure and making decisions about which services to provide with the money available.
The role of real world data and evidence in building a sustainable & efficien...Office of Health Economics
This presentation defines RWD and RWE in the context of digital health, and looks at potential uses for RWD and RWE. It briefly sets out the current landscape in Malaysia and looks at the challenges in using RWE. In particular, the issues of access, governance and ensuring good quality are considered.
The aim of this educational symposium was to discuss why we should seek value across the health care system and how we can apply existing research methods to measure the value of services. While considerable political attention in developed countries continues to be focused on drug spending, there is also growing awareness of the significant contribution of non-drug components of health care (e.g., hospital services and inefficient care delivery) to overall spending growth and patient affordability. At the same time, there is growing interest in making greater use of value assessment and value-based payment to control spending and better align it with care quality. In order to promote greater value, and to do so in ways that respond to the needs of payers and patients, it is essential to assess value across both drug- and non-drug interventions and health care services. This panel will offer expert viewpoints to identify and discuss gaps in value information, rationale and approaches to track and reduce system-wide low value care, and research methods for how to measure health care services.
Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...Office of Health Economics
Graham participated in an organised session on Monday July 15th 2019. In the session he presented his paper with his co-author Ioannis Laliotis from the London School of Economics. The paper revisits the relationship between workforce and maternity outcomes in the English NHS in an attempt to contribute knowledge to an important policy question for which there has been a paucity of research.
This research explores the feasibility of introducing an Outcome-Based Payment approach for new cancer drugs in England. A literature review explored the current funding landscape in England, the available evidence on existing OBP schemes internationally, and
which outcomes cancer patients value most. Two focus groups and an online survey with patients and carers, as well as interviews with NHS and government stakeholders, healthcare
professionals, and pharmaceutical industry representatives, provided additional evidence on the feasibility and suitability of OBP schemes
Understanding what aspects of health and quality of life are important to peopleOffice of Health Economics
Poster presentation from the EuroQol Plenary Meeting 2019, Brussels, Belgium. By Koonal Shah, Brendan Mulhern, Patricia Cubi-Molla, Bas Janssen, and David Mott.
Koonal presented as part of an organised session on ‘moving beyond conventional economic approaches in palliative and end of life care’. He summarised the empirical evidence on the extent of pubic support for an end of life premium, before discussing some novel approaches that have been used in recent studies. His presentation was discussed by Helen Mason of Glasgow Caledonian University.
Author(s) and affiliation(s): Koonal Shah, Office of Health Economics
Event: iHEA Congress
Date: 17/07/2019
Location: Basel, Switzerland
Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...Office of Health Economics
This research presented in a poster at HTAi 2019, Cologne (Germany) by a team of OHE and IHE researchers, estimates the value added by second generation antipsychotics over their life-cycle in the UK and Sweden. It concludes that considering the entire life-cycle, the value added by SGAs to the system is higher than the expected value estimated at launch. P&R decisions should consider how to measure, capture and take into account the value added by medicines over the long-run.
Author(s) and affiliation(s): Mikel Berdud (Office of Health Economics, London), Niklas Wallin-Bernhardsson (Institute for Health Economics, Stockholm), Bernarda Zamora (Office of Health Economics, London), Peter Lindgren (Institute for Health Economics, Stockholm), Adrian Towse (Office of Health Economics, London)
Event: HTAi 2019 Annual Meeting
Date: 18/06/2019
Location: Cologne, Germany
There is growing recognition that HTA and contracting systems for antimicrobials need to be adapted to help fight the threat of antimicrobial resistance (AMR), but there is little agreement on how. This poster reports findings from a literature review, expert interviews and face-to-face discussions at a Forum on the current HTA and payment systems for antibiotics across Europe and a number of recommendations for adapting these systems to respond to the challenges of AMR.
Author(s) and affiliation(s): Margherita Neri (OHE) Grace Hampson (OHE) Christopher Henshall (OHE visiting fellow, independent consultant) Adrian Towse (OHE)
Event: HTAi annual conference 2019
Date: 18/06/2019
Location: Cologne, Germany
Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...Office of Health Economics
This study aims to guide access decisions and drive the discussion on access and price, through recognition of the dynamic nature of value added by pharmaceutical innovation over the long-run. The analysis of the life-cycle value of risperidone estimates the value generated in the UK and Sweden. Results show that health systems were able to appropriate most of the life-cycle value generated, and this is larger than estimated at launch.
Author(s) and affiliation(s): Mikel Berdud(1), Niklas Wallin-Bernhardsson(2), Bernarda Zamora(1), Peter Lindgren(2), and Adrian Towse(1) (1) Office of Health Economics (2) The Swedish Institute for. Health Economics
Event: XXXIX JORNADAS DE ECONOMÍA DE LA SALUD
Date: 12/06/2019
Location: Albacete, Spain
Prescribed Specialised Services (PSS) Commissioning for Quality and Innovation (CQUIN) schemes were launched in 2013 in England with the aim of improving the quality of specialised care and achieving value for money. During this presentation, Marina Rodes Sanchez described the key features of the schemes and discussed its strengths and weaknesses based on international pay-for-performance literature.
Author(s) and affiliation(s): Yan Feng, Queen Mary University of London; Søren Rud Kristensen, Imperial College London; Paula Lorgelly, King’s College London; Rachel Meacock, University of Manchester; Marina Rodes Sanchez, Office of Health Economics; Luigi Siciliani, University of York; Matt Sutton, University of Manchester
Event: XXXIX Spanish Health Economics Association Conference
Date: 12/06/2019
Location: Albacete, Spain
In this session, Meng Li sets out estimates of real option value for drugs arguing that option value matters and can be calculated. Adrian Towse sets out likely payer concerns about incorporating real option value into decision making. Meng Li responds to these concerns. Jens Grueger sets out how industry considers investment opportunities, arguing that if patients (and society) have preferences these need to be reflected in P&R decisions.
Author(s) and affiliation(s): Meng Li, Postdoctoral Research Fellow, Leonard D Schaeffer Center, University of Southern California, Los Angeles, CA, USA. Adrian Towse, Emeritus Director, Office of Health Economics, London, UK Jens Grueger, formerly Head of Global Access, Senior Vice President at F. Hoffmann-La Roche
Event: ISPOR 2019
Location: New Orleans, USA
Date: 21/05/2019
MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...Office of Health Economics
In this ISPOR session Chuck Phelps and Adrian Towse debated the case for and against using MCDA to support HTA decision making, as compared to weighting or augmenting a QALY based ICER approach. Chuck Phelps argued for use of MCDA, Adrian Towse for weighting the QALY. Nancy Devlin set the scene and moderated.
Author(s) and affiliation(s): Nancy Devlin, Director, Centre for Health Policy, University of Melbourne, Australia Adrian Towse, Emeritus Director, Office of Health Economics, London, UK Chuck Phelps, University of Rochester, Rochester, NY USA
Event: ISPOR 2019
Location: New Orleans, USA
Date: 21/05/2019
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Rate Controlled Drug Delivery Systems, Activation Modulated Drug Delivery Systems, Mechanically activated, pH activated, Enzyme activated, Osmotic activated Drug Delivery Systems, Feedback regulated Drug Delivery Systems systems are discussed here.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
PET CT beginners Guide covers some of the underrepresented topics in PET CTMiadAlsulami
This lecture briefly covers some of the underrepresented topics in Molecular imaging with cases , such as:
- Primary pleural tumors and pleural metastases.
- Distinguishing between MPM and Talc Pleurodesis.
- Urological tumors.
- The role of FDG PET in NET.
Under Pressure : Kenneth Kruk's StrategyKenneth Kruk
Kenneth Kruk's story of transforming challenges into opportunities by leading successful medical record transitions and bridging scientific knowledge gaps during COVID-19.
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
COVID-19 PCR tests remain a critical component of safe and responsible travel in 2024. They ensure compliance with international travel regulations, help detect and control the spread of new variants, protect vulnerable populations, and provide peace of mind. As we continue to navigate the complexities of global travel during the pandemic, PCR testing stands as a key measure to keep everyone safe and healthy. Whether you are planning a business trip, a family vacation, or an international adventure, incorporating PCR testing into your travel plans is a prudent and necessary step. Visit us at https://www.globaltravelclinics.com/
The Importance of COVID-19 PCR Tests for Travel in 2024.pptx
What Does Patient-centred Care Mean for Medicine in the Welfare States of Europe: A Response to Peter Zweifel
1. What Does Patient-centered Care Mean for
Medicine in the Welfare States of Europe?
A response to Peter Zweifel
Adrian Towse
Director of the Office of Health Economics and
Visiting Professor, London School of Economics
ISPOR Barcelona 2018
2. Rebuttal Part 1
• Patient centredness yes, but also 3rd
party insurance. Payer
decides what is available. Patient has to top up if they want
more.
• Will premiums need to go up if there is full coverage?
• Higher patient preference because …?
• Additional value of patient knowledge that the treatment will work?
“Value of knowing?1
”
• Lower volumes, so cost per unit goes up?
• Original Danzon and Towse2
argument was that health gain was
concentrated in fewer patients, prices higher but revenues
unchanged
• There may be rare diseases for which there are few patients but not
obvious this is the norm. But it will push up health care costs
• Will clinical consultation will take longer? Possible, but also
reduced need for repeat visits because of treatment failure?
1
Garrison, L., Kamal-Bahl, S., Towse, A. Toward a Broader Concept of Value: Identifying and Defining Elements for an
Expanded Cost-Effectiveness Analysis. Value in Health 2017 Feb;20(2):213-216
2
Danzon, P. and Towse, A. (2002) The economics of gene therapy and of pharmacogenetics. Value in Health. 5(1), 5-13.
3. Rebuttal Part 2
• I agree (i) it is share of public spend that
matters and (ii) that it is redistributive
• But it is “pay as you go” publicly funded
pensions and long term care as well as health
care that are the challenges for Europe1
• And lets be clear that the income redistribution
is very very effective
1
Pammolli F., 2013. Demography, Sustainability and Growth. Notes on The Future of The European “Social Market”
Economy. CERM Working Paper. Available at
http://www.cermlab.it/wpcontent/uploads/cerm/Scocialmarketeconomy_final_oct20_fp.pdf
4. Cost-Related Access Barriers in the Past Year, by
Income
Source: Slide from Peter Smith, OHE Annual Lecture 2018, forthcoming. Information sourced from 2016
Commonwealth Fund International Health Policy Survey, R. Osborn, D. Squires, M. M. Doty, D. O. Sarnak, and E. C.
Schneider, "In New Survey of 11 Countries, U.S. Adults Still Struggle with Access to and Affordability of Health Care,"
Health Affairs Web First, Nov. 16, 2016.
Percent
*Indicates differences are significant at p<0.05.
Note: “Low income” defined as household income less than 50% the country median. Sample sizes are small (n<100) in the Netherlands and
UK.
Had a medical problem but did not visit doctor;
skipped medical test, treatment or follow up
recommended by doctor; and/or did not fill
prescription or skipped doses
5. English NHS Lifetime hospital costs:
multiple of annual income by quintile
2011/12
Deprivation
Quintile
Annual
Income £
Lifetime Hospital Costs £ Times annual income
Male Female Male Female
Most deprived 1 11492 50163 59255 4.37 5.16
2 16900 47743 54853 2.83 3.25
3 22204 45561 51701 2.05 2.33
4 29536 44291 49594 1.50 1.68
Least deprived 5 44980 43358 48409 0.96 1.08
Source: Peter Smith, OHE Annual Lecture 2018, forthcoming. Calculations from Asaria M, Doran T, Cookson R. 2016, “The costs of inequality:
whole-population modelling study of lifetime inpatient hospital costs in the English National Health Service by level of neighbourhood deprivation”,
J Epidemiol Community Health doi:10.1136/jech-2016-207447 and Department for Work and Pensions (2013)
Households Below Average Income. An analysis of the income distribution 1994/95 – 2011/12
6. Rebuttal Part 3
• I am not aware of an equivalent UK DCE. I am aware of opinion
poll surveys that show a willingness to pay higher taxes for
more health care, but the reality is that the political party
proposing lower taxes often wins the election.
• How do we make sense of this? Paying for social insurance / tax
based insurance or any form of income based contributions to a
community rated insurance pool consists of two parts:
• (i) payment to a pool from which we get care (let’s use Nyman1
categorisation of a transient income transfer, when the care we
need is provided and paid for) and
• (ii) expressing a preference over your willingness to buy care
for other people.
• In the case of some schemes e.g US Medicaid, then it is a pure
expression of redistributive preference for health care.
1
Kelman S., and Woodward A. 2013. John Nyman and the Economics of Health Care Moral Hazard. ISRN
Economics, Volume 2013, Article ID 603973,
7. Final thoughts
• This may help also to explain the gap between demand side
opportunity cost WTP for health gain (v) and supply side budget
constrained opportunity cost (k). We are making a contribution
to the care of others beyond an actuarially fair insurance policy,
i.e. WTP = f(v+θ) where θ < v
• So what is this telling us about the future of health care in
Europe?
• There remains a problem of tax aversion and the likelihood that
healthcare will rise as a share of GDP. This is about preferences
for health and for equity as much as patient centred care.
• There is a separate issue of willingness to redistribute income
to support access to health.
• If this is limited then the minimum supported package covers
less healthcare for fellow citizens.
• Will WTP for altruism rise with income? Isn’t it a superior good?